UNSPSC 51282914: Gemifloxacin

This classification denotes a quinolone antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OKR68Y0E4T. European Medicines Agency schedules Gemifloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB27752. Gemifloxacin generally arises in the molecular formula C18H20FN5O4. The term GEMIFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, no. 1, 2000, list 43.) Most nations schedule gemifloxacin under HS 29339990 and SITC 51577.

As of Q4 2014, GEMIFLOXACIN remains the US FDA Preferred Term for this commodity. Gemifloxacin bears US NLM identifiers UMLS ID C0533545 and NCI Concept Code C61775. SMILES: FC1C(N2CC(/C(=N\OC)C2)CN)NC2N(C3CC3)CC(C(=O)C2C1)C(=O)O.

UNSPSC 51282914 Gemifloxacin is a Commodity code within the pharmaceutical supply taxonomy. Recent state and local procurement activity tagged to this code shows little direct connection to gemifloxacin itself; instead, the opportunities on record reflect broader pharmaceutical warehouse and drug-supply procurement by state health departments and county health authorities. State and local governments use codes in this family to buy antibiotics, antiretrovirals, and emergency medical countermeasures through piggyback contracts with pharmaceutical distributors and via competitive bidding for specific drug products and medical supplies. The issuing bodies include state public health departments, county health systems, and special-purpose health districts seeking regular inventory replenishment, emergency stockpiles, or public health response supplies.

Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for the supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets over a $2,999,999.11 contract spanning 12 months with two optional renewal years; this was an Invitation for Bid process. Seminole County, Florida issued an IFB (IFB60459723LAS) posted June 30, 2026, to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. Recent activity clusters in Florida and Illinois; no geographic concentration emerges from the limited sample. The code shows sparse recent activity, with awarded and historical opportunities dominating the record rather than open solicitations.